UPDATE : Wednesday, September 26, 2018
상단여백
Which multinational drugmaker grew most rapidly in H1? by Nam Doo-hyun 2018-07-25 11:52
Pfizer Korea stops recruitment procedure by Lee Han-soo 2018-07-24 17:01
Antidiabetic drug Zemiglo up, cancer drug Supect down in H1 sales by So Jae-hyeon 2018-07-24 11:11
Stock declines, negative rumors haunt biotech industry by So Jae-hyeon 2018-07-23 16:39
Il-yang gets 1-month suspension on quadrivalent flu vaccine by Lee Hye-seon 2018-07-20 14:58
라인
Latecomer Lixiana’s chase after Eliquis gets faster by So Jae-hyeon 2018-07-20 12:01
Bifido wins patent for microbiome-based treatment in US by So Jae-hyeon 2018-07-19 15:42
Xofigo combinations raise fracture risk by Lee Hye-seon 2018-07-19 13:59
Joint R&D program to test Keytruda combo in breast cancer patients by Marian Chu 2018-07-18 17:53
Kolon Life Science inks deal to sell Invossa to China by So Jae-hyeon 2018-07-18 16:46
라인
L&K Biomed gets FDA nod for sacroiliac joint disease implant system by Marian Chu 2018-07-18 16:26
SK Bioscience to expand vaccine production facility by Marian Chu 2018-07-18 16:13
ViroMed secures DNA production plant in US by Marian Chu 2018-07-18 15:02
Dong-A ST’s Jublia dominates athlete’s foot drugs by So Jae-hyeon 2018-07-18 11:50
Novo Nordisk Korea gets nod for diabetes drug Fiasp by Marian Chu 2018-07-18 11:50
라인
‘Koreans increasingly seeking out hair loss treatment’ by Marian Chu 2018-07-17 16:08
YD Life Science to proceed with P2 trial for diabetic retinopathy treatment by Lee Han-soo 2018-07-17 14:52
30% of psoriasis patients take more than 5 years to find correct therapy by Marian Chu 2018-07-17 14:52
Pharmbio launched CINV treatment by Lee Han-soo 2018-07-17 14:02
Korean eye drops selling well overseas by So Jae-hyeon 2018-07-17 11:36
여백
여백
여백
Back to Top